US 12,285,418 B1
2-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the treatment of acute myeloid leukemia
Roaa M. Alreemi, Jeddah (SA); Hind A. Alkhatabi, Jeddah (SA); Abdelsattar M. Omar, Jeddah (SA); Mohammed A. Baradwan, Jeddah (SA); Yosra A. Muhammad, Jeddah (SA); Peter Natesan Pushparaj, Jeddah (SA); Mohammad Basabrain, Jeddah (SA); and Moustafa E. El-Araby, Richmond, VA (US)
Assigned to University of Jeddah, Jeddah (SA); and King Abdulaziz University, Jeddah (SA)
Filed by University of Jeddah, Jeddah (SA)
Filed on Aug. 29, 2024, as Appl. No. 18/818,926.
Int. Cl. A61K 31/444 (2006.01); A61K 31/443 (2006.01); A61P 35/02 (2006.01)
CPC A61K 31/444 (2013.01) [A61K 31/443 (2013.01); A61P 35/02 (2018.01)] 4 Claims
 
1. A method for treating acute myeloid leukemia by administering to a subject in need thereof an effective amount of a compound or pharmaceutically accepted salt or solvate thereof, selected from the group consisting of

OG Complex Work Unit Chemistry